Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Microbiology"
DOI: 10.1007/s12275-018-8037-z
Abstract: Mucosal surfaces that line our gastrointestinal tract are continuously exposed to trillions of bacteria that form a symbiotic relationship and impact host health and disease. It is only beginning to be understood that the cross-talk… read more here.
Keywords: targeting friend; foe emerging; disease; therapeutics age ... See more keywords
Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15010237
Abstract: Age-related disorders of the musculoskeletal system including sarcopenia, osteoporosis and arthritis represent some of the most common chronic conditions worldwide, for which there remains a great clinical need to develop safer and more efficacious pharmacological… read more here.
Keywords: age related; related musculoskeletal; therapeutics age; oligonucleotide therapeutics ... See more keywords